Anmelden Kostenlos registrieren

Avid Bioservices Inc Zukünftige P/E

Was ist das Zukünftige P/E von Avid Bioservices Inc?

Zukünftige P/E von Avid Bioservices Inc ist 73.94

Was ist die Definition von Zukünftige P/E?



Das Terminkurs-Gewinn-Verhältnis ist das Verhältnis des Aktienkurses eines Unternehmens zum geschätzten Gewinn des Unternehmens für die nächsten zwölf Monate.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Zukünftige P/E von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Avid Bioservices Inc

Was macht Avid Bioservices Inc?

avid bioservices, a subsidiary of peregrine pharmaceuticals, inc. (nasdaq: pphm), is a unique contract manufacturing organization ("cmo") partner dedicated to the development and production of monoclonal antibodies, recombinant proteins and enzymes produced in mammalian cell culture. our extensive experience at all stages of development enables us to provide comprehensive development, manufacturing and support services to navigate a biologic from concept to commercialization.

Unternehmen mit zukünftige p/e ähnlich Avid Bioservices Inc